Vanguard Group Inc Lyell Immunopharma, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,071,482 shares of LYEL stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,071,482

Previous 13,398,298 24.83%

Holding current value

$11.1 Million

Previous $19.4 Million 28.46%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.13 - $1.88 $3.76 Million - $6.25 Million	-3,326,816 Reduced 24.83%	10,071,482 $13.9 Million
Q2 2024 Aug 13, 2024	BUY	$1.3 - $3.01 $12,834 - $29,717	9,873 Added 0.07%	13,398,298 $19.4 Million
Q1 2024 May 10, 2024	SELL	$1.71 - $3.07 $368,679 - $661,898	-215,602 Reduced 1.58%	13,388,425 $29.9 Million
Q4 2023 Feb 14, 2024	SELL	$1.39 - $2.35 $4.59 Million - $7.77 Million	-3,305,693 Reduced 19.55%	13,604,027 $26.4 Million
Q3 2023 Nov 14, 2023	BUY	$1.45 - $3.35 $47,077 - $108,764	32,467 Added 0.19%	16,909,720 $24.9 Million
Q2 2023 Aug 14, 2023	BUY	$1.89 - $3.86 $7.78 Million - $15.9 Million	4,118,130 Added 32.28%	16,877,253 $53.7 Million
Q1 2023 May 15, 2023	BUY	$1.97 - $3.58 $330,749 - $601,056	167,893 Added 1.33%	12,759,123 $30.1 Million
Q4 2022 Feb 10, 2023	BUY	$2.78 - $8.09 $513,235 - $1.49 Million	184,617 Added 1.49%	12,591,230 $43.7 Million
Q3 2022 Nov 14, 2022	BUY	$5.54 - $8.27 $9.84 Million - $14.7 Million	1,776,617 Added 16.71%	12,406,613 $90.9 Million
Q2 2022 Aug 12, 2022	BUY	$3.68 - $6.8 $6.81 Million - $12.6 Million	1,851,294 Added 21.09%	10,629,996 $69.3 Million
Q1 2022 May 13, 2022	BUY	$5.05 - $7.7 $33.5 Million - $51.1 Million	6,635,614 Added 309.63%	8,778,702 $44.3 Million
Q4 2021 Feb 14, 2022	SELL	$7.13 - $15.19 $497,182 - $1.06 Million	-69,731 Reduced 3.15%	2,143,088 $16.6 Million
Q3 2021 Nov 12, 2021	BUY	$11.0 - $17.95 $5.1 Million - $8.32 Million	463,441 Added 26.49%	2,212,819 $32.7 Million
Q2 2021 Aug 13, 2021	BUY	$15.99 - $16.89 $28 Million - $29.5 Million	1,749,378 New	1,749,378 $28.4 Million

Others Institutions Holding LYEL

# of Institutions

122

Shares Held

142M

Call Options Held

18.1K

Put Options Held

200

View Full List

About Lyell Immunopharma, Inc.

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $273M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

More about LYEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Lyell Immunopharma, Inc. Transaction History